human CD14
Kat.-Nr. |
Produkt |
VE |
rekombinantes human CD14 |
10 µg |
|
rekombinantes human CD14 (appr. 1 mg/ml) ungereinigt in serumfreiem Kulturüberstand von CHO Transfektanten |
100 µg |
|
adequater Kontrollüberstand zu 011-3a von Vector transfizierten CHO Zellen |
100 µg |
Referenzen
Schütt, C. et al. (1999): Implications for a general role of LPS - binding proteins (CD14, LBP) in combating bacterial intections. J. Endotoxin
Lipsker, D. et al. (2002): Heat shock proteins 70 and 60 share common receptors which are expressed on human moncyte - derived but not epidermal dendritic cells. Eur. J. Immunol. 32
Jack, R.S. et al.(1995): Both membrane bound and soluble forms of CD14 bind to gram negative bacteria. Eur. J. Immunol. 25, 1436
Uehara, A.; Sugawara, Sh.; Tamai, R.; Takada, H.; (2001): Contrasting responses of human gingival and colonic epithelial cells to lipopolysaccharides, lipoteichoic Acid and peptidoglycans in the presence of soluble CD14. Med. Microbiol. Immunol. 189: 185-192
Hamann,C. Alexander, C. Stamme, U. Zähringer, R.R. Schumann Acute phase concentrations of lipopolysaccaride (LPS)-Binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms, Infection and Immunity 2005, 193-200 Vol 73/1
Rivieccio M.A., G.,R. John, X. Song, H.-S. Suh, Y. Zhao, .C. Lee C.F. Brosnan The cytokine IL1β activates IFN response factor 3 in human fetal astrocytes in culture J. Immunol. 2005, 174: 3719-26
Neumeisler, B. et al. (1998): Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14. Infection and Immunity 66, 4151-4157
